Abstract
Introduction: Nail involvement in patients with crusted scabies is well known. It is characterized clinically by subungual hyperkeratosis and onycholysis. “Classical” scabies involving the nails was rarely reported. Case Presentations: We describe 2 patients with classical scabies located exclusively on a toenail. In the first patient, the complete disappearance of the nail plate was observed. In the second patient, a thick, greyish-brown nail plate, surrounded by scales, was observed. Both patients were successfully treated with permethrin and ivermectin. Conclusion: A possible explanation about the fact that scabies remained limited to only one toenail is suggested.
Journal Section:
Novel Insights from Clinical Practice
References
1.
DePaoli
RT
, Marks
VJ
. Crusted (Norwegian) scabies: treatment of nail involvement
. J Am Acad Dermatol
. 1987
;17
(1
):136
–9
. 2.
Judge
MR
, Kobza-Black
A
. Crusted scabies in pregnancy
. Br J Dermatol
. 1995
;132
(1
):116
–9
. 3.
Ohtaki
N
, Taniguchi
H
, Ohtomo
H
. Oral ivermectin treatment in two cases of scabies: effective in crusted scabies induced by corticosteroid but ineffective in nail scabies
. J Dermatol
. 2003
;30
(5
):411
–6
. 4.
Weatherhead
SC
, Speight
EL
. Crusted scabies as a cause of longitudinal nail splitting
. Clin Exp Dermatol
. 2004
;29
(3
):315
. 5.
Goyal
NN
, Wong
GA
. Psoriasis or crusted scabies
. Clin Exp Dermatol
. 2008
;33
(2
):211
–2
. 6.
Jayananda
S
, Raju
NSG
. Norwegian or crusted scabies in a patient with Down syndrome
. Inf Dis Clin Pract
. 2013
;21
:318
–9
.7.
Del Borgo
C
, Belvisi
V
, Tieghi
T
, Mastroianni
CM
. Atypical presentation of crusted (Norwegian) scabies
. Infection
. 2015
;43
(5
):623
–4
. 8.
Assaf
RR
, Wu
H
. Visual diagnosis: severe scaly pruritic rash in an 8-year-old girl with trisomy 21
. Pediatr Rev
. 2016
;37
(11
):e45
–47
. 9.
Jiang
Y
, Zhan
AT
, Qiu
F
, Fan
YM
. Serial dermoscopic monitoring of subungual scabies mites in an infant with crusted scabies
. J Eur Acad Dermatol Venereol
. 2022
;36
(6
):e492
–494
. 10.
Gaurav
V
, Tyagi
M
, Grover
C
, Das
S
. Ungual scabies: a case report and review of literature
. Skin Appendage Disord
. 2024
;10
(1
):60
–8
. 11.
Saruta
T
, Nakamizo
Y
. Usual scabies with nail infestation
. Arch Dermatol
. 1978
;114
(6
):956
–7
. 12.
Scher
RK
. Biopsies of nails. Subungual scabies
. Am J Dermatopathol
. 1983
;5
(2
):187
–9
. 13.
Witkowski
JA
, Parish
LC
. Scabies. Subungual areas harbor mites
. JAMA
. 1984
;252
(10
):1318
–9
. 14.
Isogai
R
, Kawada
A
, Aragane
Y
, Tezuka
T
. Nail scabies as an initial lesion of ordinary scabies
. Br J Dermatol
. 2002
;147
(3
):603
. 15.
Veraldi
S
, Esposito
L
, Pontini
P
, Nazzaro
G
, Schianchi
R
. Where to look for the scabies mite
. Infect Dis
. 2017
;49
(5
):427
–8
. 16.
Finon
A
, Desoubeaux
G
, Nadal
M
, Georgescou
G
, Baran
R
, Maruani
A
. Scabiose de l’appareil unguéal chez un nourrisson
. Ann Dermatol Venereol
. 2017
;144
(5
):356
–61
. 17.
Tempark
T
, Lekwuttikarn
R
, Chatproedprai
S
, Wananukul
S
. Nail Scabies: an unusual presentation often overlooked and mistreated
. J Trop Pediatr
. 2017
;63
(2
):155
–9
. 18.
Zou
Y
, Hu
W
, Zheng
J
, Pan
M
. Nail infestation: an atypical presentation of typical scabies
. Lancet
. 2018
;391
(10136
):2272
. 19.
Chinazzo
M
, Desoubeaux
G
, Leducq
S
, Bessis
D
, Droitcourt
C
, Mahe
E
, et al. Prevalence of nail scabies: a French prospective multicenter study
. J Pediatr
. 2018
;197
:154
–7
. 20.
Sechi
A
, Chessa
MA
, Patrizi
A
, Savoia
F
, Neri
I
. Periungual scabies in infants: a tough reservoir of mites presenting with lamellar desquamation
. Arch Dis Child
. 2020
;105
(7
):703
. 21.
Talaga-Ćwiertnia
K
, Salamon
D
, Krzyściak
P
. Unexpected subungual Sarcoptes infestation of toenail: a case report and literature review
. Ann Parasitol
. 2021
;67
(4
):779
–87
. 22.
Veraldi
S
, De Micheli
P
, Schianchi
R
, Pontini
P
. A new treatment regimen with permethrin in scabies
. G Ital Dermatol Venereol
. 2018
;153
(4
):491
–3
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.
